Oakworth Capital’s Dentsply Sirona XRAY Stock Holding History

Oakworth Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$6K	–	595
2021 Q4	$6K	Hold	100	–	–	﹤0.01%	522
2021 Q3	$6K	Hold	100	–	–	﹤0.01%	508
2021 Q2	$6K	Buy	+100	New	+$6.59K	﹤0.01%	508
2019 Q3	–	Sell	-1,660	Closed	-$96K	–	649
2019 Q2	$96K	Buy	+1,660	New	+$89.2K	0.02%	240
2016 Q3	–	Sell	-9	Closed	-$1K	–	663
2016 Q2	$1K	Hold	9	–	–	﹤0.01%	583
2016 Q1	$1K	Hold	9	–	–	﹤0.01%	539
2015 Q4	$1K	Hold	9	–	–	﹤0.01%	521
2015 Q3	$0	Hold	9	–	–	﹤0.01%	495
2015 Q2	$1K	Hold	9	–	–	﹤0.01%	455
2015 Q1	$0	Hold	9	–	–	﹤0.01%	549
2014 Q4	$0	Hold	9	–	–	﹤0.01%	561
2014 Q3	$0	Hold	9	–	–	﹤0.01%	518
2014 Q2	$0	Hold	9	–	–	﹤0.01%	518
2014 Q1	$0	Hold	9	–	–	﹤0.01%	518
2013 Q4	$0	Buy	+9	New	+$421	﹤0.01%	503

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Oakworth Capital's XRAY Position: Q1 2022 in Review

Oakworth Capital sold out of Dentsply Sirona (XRAY) in Q1 2022, closing a stake of 100 shares — an estimated $6K sold.

Oakworth Capital first reported a position in XRAY in Q4 2013 and held it in 15 quarters. The position peaked at $96K in Q2 2019. 536 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.

Oakworth Capital reported no remaining Dentsply Sirona position as of Q1 2022 after selling out during the quarter.
Oakworth Capital sold 100 Dentsply Sirona shares in Q1 2022, an estimated $6K.
Oakworth Capital first reported a position in Dentsply Sirona in Q4 2013 and held it in 15 quarters.
Oakworth Capital's Dentsply Sirona position peaked at $96K in Q2 2019.
536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.

Based on Oakworth Capital's 13F filing for Q1 2022, filed 11 Apr 2022.